Carlyle Group Inc. INFORMATION TABLE, Q1 FY2021

SEC Form 13F Summary: Carlyle Group Inc.

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by Carlyle Group Inc. for the reporting period ending March 31, 2021. The form discloses the investment manager's holdings in equity securities as of the end of the quarter.

Key Financial Metrics and Holdings

The filing details specific equity positions held by the manager. The table below summarizes the reported holdings by issuer, share count, and total value (in thousands).

Issuer Class Shares Held Value ($000s) Voting Authority
Ortho Clinical Diagnostics H Ord Shs 2,767,019 143,406,000 Sole
Atotech Ltd Com 1,900,283 93,841,130 Sole
ZoomInfo Technologies Inc Com Cl A 4,366,102 89,286,335 Sole
Atotech Ltd Com 1,211,589 59,831,573 Sole
PPD Inc Com 2,108,548 55,722,733 Sole
Life Healthcare Inc Com 531,984 13,612,681 Sole
Liberty Oilfield Svcs Inc Com Cl A 138,867 12,299,996 Sole
Vitru Ltd Com 92,760 6,246,471 Sole
Talos Energy Inc Com 59,718 4,960,000 Sole
Onesmart Intl Ed Group Ltd Sponsored Ads 21,065 7,860,000 Sole
Physicians Rlty Tr Com 10,387 587,838 Sole
Seacor Marine Hldgs Inc Com 6,119 1,147,989 Sole
SiriusPoint Ltd Com 1,316 129,408 Sole

Note: The filing does not provide aggregate portfolio value, revenue, profit, cash flow, or debt metrics for Carlyle Group Inc. itself, as Form 13F only reports specific equity holdings.

Material Changes and Guidance

The filing text does not provide comparative data against the prior period (December 31, 2020) to determine material changes in holdings. Consequently, no analysis of increases or decreases in positions can be derived from this document alone. There is no management commentary, guidance, outlook, or discussion of risks and contingencies included in this specific filing type.

Investor Verification Checklist

  • Portfolio Concentration: Verify if the top three holdings (Ortho Clinical Diagnostics, Atotech Ltd, ZoomInfo Technologies) represent a significant portion of the total managed assets.
  • Position Changes: Compare these March 31, 2021 holdings against the December 31, 2020 Form 13F to identify new entries or exits.
  • Voting Rights: Confirm that "Sole" voting authority applies to all listed positions, indicating full control over voting decisions for these shares.
  • Valuation Accuracy: Cross-reference the reported values with market prices as of March 31, 2021, to ensure the reported values align with historical closing prices.